Skip to main content

Corporate insider profile

Chandler Robinson Insider Trades

Latest reported as Chief Executive Officer of Monopar Therapeutics (MNPR).

Purchase filings
0
Reported companies
1
Net open-market value
-$2,556,849.55
Latest transaction
Sep 24, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 24, 2026Monopar Therapeutics (MNPR)Chief Executive OfficerSale29,056$88.00$2,556,850